Xencor, Inc. , a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today announced that it has initiated dosing of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback